You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Merck Agrees to $1 Billion Investment in Germany

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 628 Words

GALWAY, IRELAND--April 9, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Merck KGaA (NYSE:MRK) (Darmstadt, Germany) is committing its future to its Darmstadt HQ in Germany with a commitment to invest 1 billion euro ($1.12 billion) there over the next six years.

Within this article: Details major investment in German HQ, proposed manufacturing projects and related plant investment project in Switzerland

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00